MA52365A - Composés et leurs utilisations - Google Patents
Composés et leurs utilisationsInfo
- Publication number
- MA52365A MA52365A MA052365A MA52365A MA52365A MA 52365 A MA52365 A MA 52365A MA 052365 A MA052365 A MA 052365A MA 52365 A MA52365 A MA 52365A MA 52365 A MA52365 A MA 52365A
- Authority
- MA
- Morocco
- Prior art keywords
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862662673P | 2018-04-25 | 2018-04-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA52365A true MA52365A (fr) | 2021-03-03 |
Family
ID=68290767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA052365A MA52365A (fr) | 2018-04-25 | 2019-04-24 | Composés et leurs utilisations |
Country Status (6)
Country | Link |
---|---|
US (1) | US10919885B2 (fr) |
EP (1) | EP3784234A1 (fr) |
JP (1) | JP2021522253A (fr) |
CN (1) | CN112566636A (fr) |
MA (1) | MA52365A (fr) |
WO (1) | WO2019209962A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019533022A (ja) | 2016-10-24 | 2019-11-14 | ユマニティ セラピューティクス,インコーポレーテッド | 化合物及びその使用 |
US11873298B2 (en) | 2017-10-24 | 2024-01-16 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
CA3157173A1 (fr) * | 2019-10-09 | 2021-04-15 | Praxis Biotech LLC | Modulateurs atf6 et leurs utilisations |
AU2020361484A1 (en) * | 2019-10-09 | 2022-05-12 | Altos Labs, Inc. | ATF6 modulators and uses thereof |
IL299664A (en) | 2020-09-03 | 2023-03-01 | Hoffmann La Roche | Heterocyclic compounds |
CR20230496A (es) * | 2021-04-23 | 2023-11-15 | Hoffmann La Roche | Compuestos heterocíclicos |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006502134A (ja) | 2002-08-09 | 2006-01-19 | アストラゼネカ アクチボラグ | 代謝調節型グルタミン酸受容体において活性を有する化合物 |
NZ547965A (en) | 2003-12-24 | 2009-12-24 | Prosidion Ltd | 1,2,4-Oxadiazole derivatives as GPCR receptor agonists |
PL1771421T3 (pl) | 2004-07-26 | 2009-08-31 | Serono Lab | Pochodne N-hydroksyamidowe i ich zastosowanie |
JP5149009B2 (ja) | 2004-09-20 | 2013-02-20 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | ヒトステアロイル−CoAデサチュラーゼを阻害するためのピリダジン誘導体 |
TW200626154A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
WO2006130986A1 (fr) | 2005-06-09 | 2006-12-14 | Merck Frosst Canada Ltd. | Derives d'azacyclohexane comme inhibiteurs de la stearoyl-coenzyme a delta-9 desaturase |
PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
CA2654792A1 (fr) | 2006-06-12 | 2007-12-21 | Merck Frosst Canada Ltd. | Derives d'azetidine comme inhibiteurs de la stearoyl-coenzyme a delta-9 desaturase |
EA200900820A1 (ru) | 2006-12-20 | 2010-02-26 | Новартис Аг | 2-замещенные 5-членные гетероциклы в качестве ингибиторов стеароил-соа-десатуразы (ссд) |
EP2197873B1 (fr) | 2007-09-20 | 2014-07-16 | Irm Llc | Composés et compositions en tant que modulateurs de l'activité de gpr119 |
GB0722077D0 (en) * | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds |
EP2219646A4 (fr) * | 2007-12-21 | 2010-12-22 | Univ Rochester | Procédé permettant de modifier la durée de vie d'organismes eucaryotes |
JP2011518774A (ja) | 2008-03-20 | 2011-06-30 | フォレスト・ラボラトリーズ・ホールディングス・リミテッド | ステアロイル−CoAデサチュラーゼの阻害剤としての新規ピペリジン誘導体 |
TWI434842B (zh) | 2008-07-14 | 2014-04-21 | Astellas Pharma Inc | Azole compounds |
WO2010022055A2 (fr) | 2008-08-20 | 2010-02-25 | Amgen Inc. | Inhibiteurs de canaux sodiques sensibles au potentiel |
WO2010039186A2 (fr) | 2008-09-23 | 2010-04-08 | Renovis, Inc. | Composés utiles en tant que modulateurs de la faah et leurs utilisations |
US20120010186A1 (en) | 2009-03-23 | 2012-01-12 | Merck Frosst Canada Ltd. | Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
CA2783575C (fr) | 2009-12-23 | 2018-06-05 | Jasco Pharmaceuticals, LLC | Inhibiteurs de l'aminopyrimidine kinase |
EP2751105A1 (fr) | 2011-09-01 | 2014-07-09 | Irm Llc | Composés et compositions pouvant être utilisés en tant qu'inhibiteurs de la kinase c-kit |
EP2766000A2 (fr) | 2011-10-15 | 2014-08-20 | F.Hoffmann-La Roche Ag | Procédés d'utilisation d'antagonistes de scd1 |
WO2013130625A1 (fr) | 2012-02-27 | 2013-09-06 | Basil Rigas | Dérivés de phospho-ester et leurs utilisations |
BR112015007516A2 (pt) | 2012-10-10 | 2017-07-04 | Actelion Pharmaceuticals Ltd | antagonistas do receptor de orexina que são derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)- pirrolidin-1-il]-metanona |
CN107249583B (zh) * | 2015-02-09 | 2021-05-07 | 国立大学法人冈山大学 | 乳酸脱氢酶抑制剂以及含有该抑制剂的抗癫痫剂 |
JP2019533022A (ja) | 2016-10-24 | 2019-11-14 | ユマニティ セラピューティクス,インコーポレーテッド | 化合物及びその使用 |
-
2019
- 2019-04-24 EP EP19792116.6A patent/EP3784234A1/fr not_active Withdrawn
- 2019-04-24 CN CN201980042740.2A patent/CN112566636A/zh active Pending
- 2019-04-24 WO PCT/US2019/028928 patent/WO2019209962A1/fr unknown
- 2019-04-24 JP JP2020559520A patent/JP2021522253A/ja active Pending
- 2019-04-24 MA MA052365A patent/MA52365A/fr unknown
- 2019-04-24 US US16/393,183 patent/US10919885B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2019209962A8 (fr) | 2020-04-09 |
CN112566636A (zh) | 2021-03-26 |
US10919885B2 (en) | 2021-02-16 |
EP3784234A1 (fr) | 2021-03-03 |
JP2021522253A (ja) | 2021-08-30 |
WO2019209962A1 (fr) | 2019-10-31 |
US20190330198A1 (en) | 2019-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA50256A (fr) | Composés de pyrazolopyrimidinone et leurs utilisations | |
MA52483A (fr) | Dérivés de gip et leurs utilisations | |
MA50618A (fr) | Polyrhérapies et leurs utilisations | |
MA43205A (fr) | Composés pyy sélectifs et leurs utilisations | |
MA54555A (fr) | Agonistes de glp-1r et leurs utilisations | |
MA41598A (fr) | Composés thérapeutiques de pyridazine et leurs utilisations | |
MA52365A (fr) | Composés et leurs utilisations | |
MA49537A (fr) | Anticorps anti-lag3 et leurs utilisations | |
MA47789A (fr) | Anticorps anti-phf-tau et leurs utilisations | |
MA50173A (fr) | Composés activateurs de bisamide sarcomère et leurs utilisations | |
MA46990A (fr) | Compositions de glp-1 et leurs utilisations | |
MA42622A (fr) | Agents de liaison à tigit et leurs utilisations | |
MA45943A (fr) | Compositions ignifuges et leurs utilisations | |
MA43284A (fr) | Composés et leurs méthodes d'utilisation | |
MA46471A (fr) | Protéines actriib à variant et leurs utilisations | |
MA52092A (fr) | Composés et leurs utilisations | |
MA49047A (fr) | Composés inhibiteurs d'ask1 et utilisations associées | |
MA45125A (fr) | Anticorps anti-alpha-synucléine et leurs utilisations | |
MA55385A (fr) | Composés et leurs utilisations | |
MA43567A (fr) | Anticorps pacap et leurs utilisations | |
MA49886A (fr) | Anticorps anti-par2 et leurs utilisations | |
MA45857A (fr) | Composés et compositions, et utilisations associées | |
MA55083A (fr) | Polyribonucléotides et leurs utilisations cosmétiques | |
MA43141A (fr) | Nouveaux composés et leurs utilisations | |
MA48956A (fr) | Composés mic-1 et utilisations associées |